IMPORTANT UPDATES

PRIVACY POLICY UPDATES PLOS has updated its Privacy Policy to make it clearer how and why we may contact you. You can read about these changes here.

COVID-19 RESEARCH UPDATES We’re here to support researchers. Visit our COVID-19 page for links to emerging research, updates about our policies, and more resources related to the pandemic. View the page

When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.

Cancer Treatment and Research

Empowering a community publishing articles in Oncology, Immunotherapy, Cancer Diagnostics, Screening and Cancer translational studies

To date, over 13,358 articles in Cancer treatment and research have been published with more than 278,308 citations from authors in 132 countries.

Join thousands of your peers who choose PLOS to represent their Cancer research.

Our community is a collaboration between authors, editors and reviewers. In-house editorial subject experts work alongside section editors, academic editors, and journal editorial boards to provide accurate assessment that readers can trust.

We put clinicians, practitioners, researchers and patients first, collaborating to make medical and life science research, and the process of publishing this research, fair, equitable, and accessible for the whole community.

RELATED CONTENT
Cancer Advances

Our expert team of Guest Editors are eager to create a Special Issue that aims to help the cancer research community to reduce the global mortality rate in cancer patients and develop new technologies for early tumor detection and minimal residual disease.

Submit Your Research
Drug Delivery

In this PLOS ONE Call for Papers, our expert Guest Editors aim to compile a range of research to advance on the recent developments in the area of drug discovery.

Read more...
Cancer Metastasis

Topics include: Cell migration, Cell adhesion, Cytoskeletal dynamics, Tumour microenvironment, Metastatic biomarkers, Anti-metastatic therapies

Read more...
COMMUNITY SPOTLIGHT
I come from a developing country and having Open Science is crucial for advancing as it will allow more talented individuals with unique ideas to move the field forward. In my opinion, this is crucial to progress.
Dr. Dukagjin Blakaj
Dukagjin Blakaj MD PhD
The James Cancer Center, Ohio State University, Columbus, United States of America
WE WANT TO HEAR FROM YOU
  • Share your opinion!

What’s important to you when you share your research?

We’d like to hear what’s important to you when you choose to share your work, especially in the context of the current climate.

UPCOMING CONFERENCES

PLOS will be attending a number of Cancer related events through 2020. More details to follow.

Back to top